Symrise refines its mid-term strategy, shares under analyst scrutiny

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-26, 12:36.

Symrise (DE000SYM9999) continues to work toward its 2025 and 2028 financial targets after reporting a mixed first quarter 2026, with the shares listed in the MDAX and trading on Xetra. The current focus is on how the group executes its strategy in the face of muted demand in parts of the consumer goods sector, according to recent analyst comments.

What recent analysis signals

UBS reaffirmed its Buy rating on Symrise on 18 June 2026 with a price target of 94 euros, citing the German group’s solid positioning in fragrances, flavors and nutrition and the potential for margin recovery as raw material inflation eases; the bank expects organic growth above 5 percent per year in the medium term, according to a summary on MarketScreener.Analyst overview on MarketScreener

JPMorgan remains constructive as well and keeps an Overweight recommendation with a 100 euro target, pointing to Symrise’s diversified customer base and structural exposure to long-term trends such as pet food and natural ingredients, as reported in early June 2026.JPMorgan target summary The consensus compiled by MarketScreener shows a mixed but broadly positive picture, with a majority of analysts on Buy or Outperform and an average target in the mid?90 euro range.

How the long-term plan looks

In its 2025 and 2028 ambitions, Symrise aims for organic sales growth of 5 to 7 percent per year and an EBITDA margin of around 20 percent, supported by a mix of efficiency measures and portfolio shifts toward higher-value applications, according to the company’s guidance and recent presentations.Symrise investor presentations Management continues to emphasize bolt-on acquisitions in targeted niches rather than large-scale deals.

The group’s Q1 2026 performance already showed that parts of the order book in pet food and nutrition remained robust, while personal care and fine fragrance volumes were still normalizing after strong years during and after the pandemic, as documented in the April 29, 2026 earnings call transcript.Q1 2026 earnings call summary Symrise confirmed its full-year guidance for 2026 in that context, aiming for organic growth in the mid-single-digit range.

The products behind the numbers

Symrise generates its revenues from fragrances, flavors and functional ingredients for cosmetics, food, beverages and pet food, with leading examples including fragrance compositions for global consumer brands and taste solutions for dairy and beverage products. The company also supplies nutrition ingredients for pet food and human health applications.

Where the Symrise shares trade now

The Symrise shares (DE000SYM9999) most recently traded on Xetra at 88.44 euros as of 2026-06-25, 17:45, according to exchange data.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.